Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

EJHaem

Showing results (531-540 of 930) with videos related to

Pageof 93
Sort By:
Ejhaem|July 18, 2022
Fetal-haemoglobin enhancing genotype at <i>BCL11A</i> reduces HbA<sub>2</sub> levels in patients with sickle cell anaemiaTitilope A Adeyemo, Oyesola O Ojewunmi, Idayat Ajoke Oyetunji, et al.
Ejhaem|July 18, 2022
Gene expression profiling impacts treatment decision making in newly diagnosed multiple myeloma patients in the prospective PROMMIS trialNoa Biran, Binod Dhakal, Suzanne Lentzsch, et al.
Ejhaem|July 18, 2022
A mutant fibrinogen that is unable to form fibrin can improve renal phenotype in mice with sickle cell anemiaMarilou G Narciso, Blair Hoeting, Jeanne M James, et al.
Ejhaem|July 18, 2022
Acalabrutinib in management of chronic lymphocytic leukemia: An Indian perspectiveNitin Sood, Abraham Varghese, Joydeep Chakrabarty, et al.
Ejhaem|July 18, 2022
Family history of any cancer for childhood leukemia patients in SwedenXinjun Li, Kristina Sundquist, Jan Sundquist, et al.
Ejhaem|July 18, 2022
Decitabine mildly attenuates <i>MLL</i>-rearranged acute lymphoblastic leukemia in vivo, and represents a poor chemo-sensitizerPauline Schneider, Patricia Garrido Castro, Sandra M Pinhanços, et al.
Ejhaem|July 18, 2022
Minimal residual disease negativity by next-generation flow in non-CR myeloma patientsSung-Min Kim, Naery Euphrasia Yang, Dajeong Jeong, et al.
Ejhaem|July 18, 2022
The net benefit of thrombolysis in the management of intermediate risk pulmonary embolism: Systematic review and meta-analysisPedro E Alcedo, Herney Andrés García-Perdomo, Cristhiam M Rojas-Hernandez
Ejhaem|July 18, 2022
Adult secondary hemophagocytic lymphohistiocytosisAntonina Obayo, Karishma Sharma, Caroline Mithi, et al.
Ejhaem|July 18, 2022
Clinical features of anthracycline-induced cardiotoxicity in patients with malignant lymphoma who received a CHOP regimen with or without rituximab: A single-center, retrospective observational studyTakafumi Nakayama, Yoshiko Oshima, Shigeru Kusumoto, et al.
Pageof 93

Showing results (531-540 of 930) with videos related to

Sort By:
Pageof 93
Ejhaem|July 18, 2022
Fetal-haemoglobin enhancing genotype at <i>BCL11A</i> reduces HbA<sub>2</sub> levels in patients with sickle cell anaemiaTitilope A Adeyemo, Oyesola O Ojewunmi, Idayat Ajoke Oyetunji, et al.
Ejhaem|July 18, 2022
Gene expression profiling impacts treatment decision making in newly diagnosed multiple myeloma patients in the prospective PROMMIS trialNoa Biran, Binod Dhakal, Suzanne Lentzsch, et al.
Ejhaem|July 18, 2022
A mutant fibrinogen that is unable to form fibrin can improve renal phenotype in mice with sickle cell anemiaMarilou G Narciso, Blair Hoeting, Jeanne M James, et al.
Ejhaem|July 18, 2022
Acalabrutinib in management of chronic lymphocytic leukemia: An Indian perspectiveNitin Sood, Abraham Varghese, Joydeep Chakrabarty, et al.
Ejhaem|July 18, 2022
Family history of any cancer for childhood leukemia patients in SwedenXinjun Li, Kristina Sundquist, Jan Sundquist, et al.
Ejhaem|July 18, 2022
Decitabine mildly attenuates <i>MLL</i>-rearranged acute lymphoblastic leukemia in vivo, and represents a poor chemo-sensitizerPauline Schneider, Patricia Garrido Castro, Sandra M Pinhanços, et al.
Ejhaem|July 18, 2022
Minimal residual disease negativity by next-generation flow in non-CR myeloma patientsSung-Min Kim, Naery Euphrasia Yang, Dajeong Jeong, et al.
Ejhaem|July 18, 2022
The net benefit of thrombolysis in the management of intermediate risk pulmonary embolism: Systematic review and meta-analysisPedro E Alcedo, Herney Andrés García-Perdomo, Cristhiam M Rojas-Hernandez
Ejhaem|July 18, 2022
Adult secondary hemophagocytic lymphohistiocytosisAntonina Obayo, Karishma Sharma, Caroline Mithi, et al.
Ejhaem|July 18, 2022
Clinical features of anthracycline-induced cardiotoxicity in patients with malignant lymphoma who received a CHOP regimen with or without rituximab: A single-center, retrospective observational studyTakafumi Nakayama, Yoshiko Oshima, Shigeru Kusumoto, et al.
Pageof 93